Ron Chiarello, PhD’s Post

View profile for Ron Chiarello, PhD, graphic

Dynamic Leader | Founder & CEO | Innovator in High-Tech and Biotechnology | Expert in Strategic Growth, Executive Coaching, and Tech Entrepreneurship

"[Rapamycin] is the most robust and reproducible drug that we know about today for impacting not only longevity, but to the extent that we can measure various metrics of healthspan in complex animals, rapamycin also seems to positively impact pretty much every aspect of health span that we measure.” —Matt Kaeberlein Click on the image to listen Dr. Peter Attia most recent podcast on longevity and healthspan. #Rapamycin #healthspan Matt Kaeberlein #longevity #health #wellness

#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D. - Peter Attia

#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D. - Peter Attia

https://peterattiamd.com

Alexander Ioannidis

Assistant Professor of Biomolecular Engineering; Adjunct Professor Computational & Mathematical Engineering

11mo

From where I am now (Rapa Nui aka Easter Island)!

To view or add a comment, sign in

Explore topics